Diabetes, Vol 38, Issue 10 1314-1319, Copyright © 1989 by American Diabetes Association

ARTICLES

Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM

M Borkman, DJ Chisholm, SM Furler, LH Storlien, EW Kraegen, LA Simons and CN Chesterman
Garvan Institute of Medical Research St. Vincent's Hospital, Sydney New South Wales, Australia.

Fish oils, containing omega-3 fatty acids (omega 3FAs), favorably influence plasma lipoproteins in nondiabetic humans and prevent the development of insulin resistance induced by fat feeding in rats. We studied the effects of fish oils in 10 subjects (aged 42-65 yr) with mild non-insulin-dependent diabetes mellitus (NIDDM). Subjects were fed a standard diabetic diet plus 1) no supplementation (baseline), 2) 10 g fish oil concentrate (30% omega 3FAs) daily, and 3) 10 g safflower oil daily over separate 3-wk periods, the latter two supplements being given in radom order by use of a double-blind crossover design. At the end of each diet period, fasting blood glucose (FBG), insulin, and lipids were measured, and insulin sensitivity was assessed with a hyperinsulinemic-euglycemic clamp performed with [3-3H]glucose. FBG increased 14% during fish oil and 11% during safflower oil supplementation compared with baseline (P less than .05), whereas body weight, fasting serum insulin levels, and insulin sensitivity were unchanged. The absolute increase in FBG during each supplementation period correlated with the baseline FBG (fish oil, r = .83, P less than .005); safflower oil, r = .75, P = .012). Fasting plasma triglyceride levels decreased during fish oil supplementation in the 4 subjects with baseline hypertriglyceridemia (greater than 2 mM) but were not significantly reduced overall. There was no significant change in fasting plasma total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. In summary, dietary fish oil supplementation adversely affected glycemic control in NIDDM subjects without producing significant beneficial effects on plasma lipids. The effect of safflower oil supplementation was not significantly different from fish oil, suggesting that the negative effects on glucose metabolism may be related to the extra energy or fat intake.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. De Caterina, R. Madonna, A. Bertolotto, and E. B. Schmidt n-3 Fatty Acids in the Treatment of Diabetic Patients: Biological rationale and clinical data Diabetes Care, April 1, 2007; 30(4): 1012 - 1026. [Full Text] [PDF]

				I. L Mostad, K. S Bjerve, M. R Bjorgaas, S. Lydersen, and V. Grill Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 540 - 550. [Abstract] [Full Text] [PDF]

				K. McAuley and J. Mann Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance J. Lipid Res., August 1, 2006; 47(8): 1668 - 1676. [Abstract] [Full Text] [PDF]

				J. A Lovegrove, S. S Lovegrove, S. V. Lesauvage, L. M Brady, N. Saini, A. M Minihane, and C. M Williams Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians Am. J. Clinical Nutrition, June 1, 2004; 79(6): 974 - 982. [Abstract] [Full Text] [PDF]

				B. S. Fuehrlein, M. S. Rutenberg, J. N. Silver, M. W. Warren, D. W. Theriaque, G. E. Duncan, P. W. Stacpoole, and M. L. Brantly Differential Metabolic Effects of Saturated Versus Polyunsaturated Fats in Ketogenic Diets J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1641 - 1645. [Abstract] [Full Text] [PDF]

				R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]

				E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, L. Sauve, J. Bergeron, and B. J. Holub Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers Am. J. Clinical Nutrition, November 1, 2001; 74(5): 603 - 611. [Abstract] [Full Text] [PDF]

				T. A Mori, D. Q Bao, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects Am. J. Clinical Nutrition, November 1, 1999; 70(5): 817 - 825. [Abstract] [Full Text] [PDF]

				I. Toft, K. H. Bonaa, O. C. Ingebretsen, A. Nordoy, and T. Jenssen Effects of n-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension: A Randomized, Controlled Trial Ann Intern Med, December 15, 1995; 123(12): 911 - 918. [Abstract] [Full Text]